J Gynecol Oncol.
2015 Oct;26(4):249-251. 10.3802/jgo.2015.26.4.249.
Uterine carcinosarcoma/malignant mixed Mullerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy
- Affiliations
-
- 1Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK. brian.wilson@ncl.ac.uk
- 2Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, International Centre for Life, Newcastle upon Tyne, UK.
- KMID: 2345913
- DOI: http://doi.org/10.3802/jgo.2015.26.4.249
Abstract
- No abstract available.
MeSH Terms
-
Adult
Aged
Aged, 80 and over
Breast Neoplasms/*epidemiology/genetics
Carcinosarcoma/*epidemiology/genetics
Cohort Studies
England/epidemiology
Female
Genes, BRCA1
Genes, BRCA2
Hormone Replacement Therapy/*statistics & numerical data
Humans
Incidence
Kaplan-Meier Estimate
Middle Aged
Mixed Tumor, Mullerian/*epidemiology/genetics
Mutation/genetics
Neoplasms, Second Primary/*epidemiology
Uterine Neoplasms/*epidemiology/genetics
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Malignant Mixed Mullerian Tumor of Uterus after Tamoxifen Therapy for Breast Cancer
- One Case of Malignant Mixed Mullerian Tumor Developed in a Postmenopausal Woman under Hormone Therapy
- A Case of Primary Carcinosarcoma of the Uterine Corpus
- A Case of Malignant Mixed Mullerian Tumor of Uterus Developed After Pelvic Irradiation
- CT and MRI findings of vixed mullerian tumor: report of three cases
